Global gene expression profiling confirms the molecular fidelity of primary tumor-based orthotopic xenograft mouse models of medulloblastoma

Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups

(2011) David W. Ellison et al.   ACTA NEUROPATHOLOGICA

Rapid Diagnosis of Medulloblastoma Molecular Subgroups

(2011) E. C. Schwalbe et al.   CLINICAL CANCER RESEARCH

High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma

(2011) I. J. Dunkel et al.   NEURO-ONCOLOGY

Risk Stratification of Medulloblastoma: A Paradigm for Future Childhood Brain Tumor Management Strategies

(2010) Roger J. Packer   Current Neurology and Neuroscience Reports

Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome

(2010) Yoon-Jae Cho et al.   JOURNAL OF CLINICAL ONCOLOGY

A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo

(2010) L. Yu et al.   NEURO-ONCOLOGY

Role of high-dose chemotherapy for recurrent medulloblastoma and other CNS primitive neuroectodermal tumors

(2010) Amar Gajjar et al.   PEDIATRIC BLOOD & CANCER

Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2

(2008) Jennifer A. Anderton et al.   NEURO-ONCOLOGY

Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features

(2008) Marcel Kool et al.   PLoS One

Direct Orthotopic Transplantation of Fresh Surgical Specimen Preserves CD133+Tumor Cells in Clinically Relevant Mouse Models of Medulloblastoma and Glioma

(2008) Qin Shu et al.   STEM CELLS